Similar Search Results

Cheap Drugs at What Price to Innovation : Does the Compulsory Licensing of Pharmaceuticals Hurt Innovation?

Chien, Colleen V. - 2014

The patent system is built on the premise that patents provide an incentive for innovation by offering a limited monopoly to patentees. The inverse assumption that removing patent protection will hurt innovation has largely prevented the widespread use of compulsory licensing - the practice of...

Persistent link: https://www.econbiz.de/10014029626

Financing vaccines for global health security

Vu, Jonathan T.; Kaplan, Benjamin K.; Chaudhuri, Shomesh; … - In: Journal of investment management : JOIM 20 (2022) 2, pp. 51-67

Persistent link: https://www.econbiz.de/10013433610

Trends in Pharmaceutical Analysis to Foster Modern Drug Discovery by Comparative In-Silico Profiling of Drugs and Related Substances

Ganorkar, Saurabh B.; Vander Heyden, Yvan - 2022

Pharmaceutical drug analysis (PDA), besides quantifying drugs and related substances (RS), can enrich drug discovery (DD) by suggesting new leads. PDA may be extended towards comparative in-silico predictions for drugs and RS. This may lead to the assessment of drug likeliness of nontoxic RS as...

Persistent link: https://www.econbiz.de/10013303005

Drug life cycles in the pharmaceutical industry : empirical detection and consequences for R & D profitability

Bauer, Hans H. - 1998

Persistent link: https://www.econbiz.de/10013416543

Pharmaceuticals - who's afraid of '1992'?

Klepper, Gernot - 1992

Persistent link: https://www.econbiz.de/10013421731

The price of global health : drug pricing strategies to balance patient access and the funding of innovation

Schoonveld, Ed - 2011

Persistent link: https://www.econbiz.de/10013547557

Changing Innovation in the Pharmaceutical Industry : Globalization and New Ways of Drug Development

Jungmittag, Andre - 2000

analyzes these new ways in drug development in pharmaceuticals within the concept of "national systems of innovations" as well …

Persistent link: https://www.econbiz.de/10013518480

Movies, stigma and choice : evidence from the pharmaceutical industry

Aggarwal, Mayank; Chakrabarti, Anindya S.; Chatterjee, … - In: Health economics 32 (2023) 5, pp. 1019-1039

Persistent link: https://www.econbiz.de/10014278027

Restructuring the Global Vaccine Industry

Lobo, Felix - 2023

The purpose of this report is to analyse the vaccines industry under the focus of Industrial Economics as an input for the design of the pertinent instruments to promote development, manufacturing and distribution of vaccines against SARS-CoV-2 in sufficient amounts to immunize all countries as...

Persistent link: https://www.econbiz.de/10014358015

Global Pharmaceuticals : Ethics, Markets, Practices

Kleinman, Arthur (ed.); Lakoff, Andrew (ed.); … - 2006

In some parts of the world spending on pharmaceuticals is astronomical. In others people do not have access to basic or … involved in the production and distribution of pharmaceuticals into stark relief, this collection charts urgent new territory … Surveillance in Argentina -- Addiction Markets: The Case of High-Dose Buprenorphine in France -- Pharmaceuticals in Urban Ecologies …

Persistent link: https://www.econbiz.de/10014488467